Cargando…
Evidence of an increased incidence of day 3 parasitaemia in Suriname: an indicator of the emerging resistance of Plasmodium falciparum to artemether
The emerging resistance to artemisinin derivatives that has been reported in South-East Asia led us to assess the efficacy of artemether-lumefantrine as the first line therapy for uncomplicated Plasmodium falciparum infections in Suriname. This drug assessment was performed according to the recommen...
Autores principales: | Vreden, Stephen GS, Jitan, Jeetendra K, Bansie, Rakesh D, Adhin, Malti R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Oswaldo Cruz, Ministério da Saúde
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005544/ https://www.ncbi.nlm.nih.gov/pubmed/24402149 http://dx.doi.org/10.1590/0074-0276130167 |
Ejemplares similares
-
Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname
por: Vreden, Stephen GS, et al.
Publicado: (2016) -
Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname
por: Mac Donald-Ottevanger, M Sigrid, et al.
Publicado: (2017) -
Gold mining areas in Suriname: reservoirs of malaria resistance?
por: Adhin, Malti R, et al.
Publicado: (2014) -
Status of potential PfATP6 molecular markers for artemisinin resistance in Suriname
por: Adhin, Malti R, et al.
Publicado: (2012) -
Malaria serology data from the Guiana shield: first insight in IgG antibody responses to Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae antigens in Suriname
por: Labadie-Bracho, Mergiory Y., et al.
Publicado: (2020)